Navigation Links
Cancer Drug Induces HDAC Inhibitor and Enhance Long-term Memory

University of California scientists have found that cancer drug enhances long-term memory and strengthen neural connections in the brain.

A protein complex called chromatin causes genomic DNA to compress much like a telephone cord shortens as it coils. When chromatin loosens, genes associated with memory can activate more easily. Previous studies have shown that the protein CBP causes chromatin to relax, thus facilitating gene activation required for memory formation. The enzymes that reverse this process, or make the chromatin tighter, are known as HDACs. UCI scientists found in this study that HDAC inhibitors loosen chromatin and lead to stronger memory formation.

This is a fundamental aspect of molecular biology, and it is fascinating that it can impact memory, cancer and neurodegeneration and potentially other conditions such as drug addiction and other psychiatric disorders, said Marcelo Wood, assistant professor in the Department of Neurobiology .

Wood and his colleagues placed mice in a chamber and gave them mild electric shocks, Afterward, scientists injected HDAC inhibitors into the brains of mice, targeting the hippocampus, a region involved in short-term and long-term memory. A day later, the scientists returned the mice to the chamber to see how well they remembered the place in which they received the shock.

Mice treated with HDAC inhibitors froze in place significantly longer than those that did not receive the drug, indicating that the treated mice formed stronger memories of the chamber than the untreated mice. The scientists also examined brain tissue and found that neural connections in the hippocampus were stronger in the samples treated with HDAC inhibitors.

After an event, a critical window exists when memory consolidation is occurring. During that time, genes associated with memory need to be turned on for certain types of long-term memory to be formed, Wood said. For the
'"/>




Page: 1 2

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cancer Drug Induces HDAC Inhibitor and Enhance Long term Memory

(Date:5/1/2015)... May 02, 2015 The Venetian on ... http://www.thevenetiangracebay.com , and it is elegant and sophisticated, ... white and attractive turquoise hues of Grace Bay Beach. ... seven percent of leisure travelers used their smartphones throughout ... were used in the planning and researching and continued ...
(Date:5/1/2015)... Jusuru International has been awarded the prestigious ... its flagship nutritional supplement, Liquid BioCell™ Life, and the ... new logo, new packaging, new products, and new messaging. ... identify and promote programs that serve as examples of ... Jusuru International for their outstanding accomplishments and contributions to ...
(Date:5/1/2015)... 2015 The Workgroup for Electronic ... on the use of health IT to create efficiencies ... resource to the United States Government Accountability Office (GAO) ... cards in Medicare. The report, “ Potential Uses of ... released to the public on Apr. 24, 2015 and ...
(Date:5/1/2015)... DC (PRWEB) May 01, 2015 It’s raining ... and House introducing proposals to expand federal support for telemedicine. ... years that ATA has been working with Congress,” said Jonathan ... actions signify how the nation is poised to embrace the ... is one more step in fulfilling ATA’s mission to improve ...
(Date:5/1/2015)... 2015 Ernst & Young (EY) has ... Co-Founder & CSO, and Burak Sezen, Co-Founder & CTO ... Entrepreneur Of The Year® 2015 Awards in the ... is a global leader in assurance, tax, transaction and ... of the top audit companies in the world. The ...
Breaking Medicine News(10 mins):Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2
... HealthPartners hosts nine physicians from Chongqing Bureau ... HealthPartners,Institute for Medical Education is hosting ... ever to visit Minnesota. During their,three-month stay, ... care, learn about health plan and hospital ...
... 5pm Today, LAWRENCE, Mass., May 12 NxStage ... innovative dialysis products,today announced its financial results for the ... first quarter of 2008 were $31.0 million, compared to,$8.4 ... million in the fourth,quarter of 2007. Revenues in the ...
... heart failure in those with Duchenne muscular dystrophy , , ... muscular dystrophy often suffer from heart failure, but Viagra ... a new Canadian study finds. , In experiments with ... by preventing the breakdown of a compound called cGMP, ...
... impact and other influences are limiting the growth ... of frequency and severity of ... AOC ),the leading provider of global risk management and consulting ... care industry,finding for the first time in nine years of ...
... China, May 12 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Co., Inc., ... modernized traditional Chinese medicine ("TCM") based in,Chengdu, China, ... Roth Third,Annual China Discovery Tour on Tuesday, May ... will be held at the Regent Hotel in ...
... Gentiva Health,Services, Inc. (Nasdaq: GTIV ), the nation,s ... it is scheduled to,present from 2:30 p.m. to 2:55 ... Investment Research Global Health Care Conference in New York., ... via a live audio web,cast, which may be accessed ...
Cached Medicine News:Health News:First Major Chinese Medical Delegation Visits Minnesota 2Health News:NxStage Medical Reports First Quarter 2008 Results 2Health News:NxStage Medical Reports First Quarter 2008 Results 3Health News:NxStage Medical Reports First Quarter 2008 Results 4Health News:NxStage Medical Reports First Quarter 2008 Results 5Health News:NxStage Medical Reports First Quarter 2008 Results 6Health News:NxStage Medical Reports First Quarter 2008 Results 7Health News:NxStage Medical Reports First Quarter 2008 Results 8Health News:NxStage Medical Reports First Quarter 2008 Results 9Health News:NxStage Medical Reports First Quarter 2008 Results 10Health News:NxStage Medical Reports First Quarter 2008 Results 11Health News:Viagra May Protect Hearts of Some Muscular Dystrophy Patients 2Health News:Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector 2Health News:Aon Study Finds Stability in Nationwide Liability Costs in the Long Term Health Care Sector 3Health News:Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time 2Health News:Gentiva(R) Health Services to Present May 21 at 2008 Citi Investment Research Global Health Care Conference in New York 2Health News:Gentiva(R) Health Services to Present May 21 at 2008 Citi Investment Research Global Health Care Conference in New York 3
(Date:5/1/2015)... 1, 2015  Misonix, Inc. (NASDAQ: MSON ... manufactures and markets innovative therapeutic ultrasonic products for ... surgery, laparoscopic surgery and other surgical applications, announced ... the third quarter fiscal year 2015 on Thursday, ... conference call that same day, Thursday, May 7, ...
(Date:5/1/2015)... 2015  Shares of Aerie Pharmaceuticals, Inc. (NASDAQ: ... following the results of the Phase 3 Rocket 1 ... trial failing to meet its end points, compelling data ... from future studies. An analyst report on ... financial review, analyst summary, valuation, and recommendation can be ...
(Date:4/30/2015)... Calif., April 30, 2015 Omnicell, Inc. (NASDAQ: ... management solutions to healthcare systems, today announced results for ... GAAP results: Revenue for the first quarter of 2015 ... the first quarter of 2014, and down $5.3 million ... First quarter 2015 net income as reported in ...
Breaking Medicine Technology:Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27
... that a new market research report is available in its ... 2017 http://www.reportlinker.com/p0333693/Europe-ENT-Devices-Market-Outlook-to-2017.html ... Summary GlobalData,s new report, "Europe ENT Devices ... Europe ENT Devices market – France, Germany, Italy, Spain and ...
... 20, 2011 Boston Scientific Corporation (NYSE: BSX ... March 31, 2011, as well as net sales and earnings ... guidance for the full year 2011. The Company exceeded its ... EPS guidance for the full year 2011. First quarter GAAP ...
Cached Medicine Technology:Reportlinker Adds Europe ENT Devices Market Outlook to 2017 2Reportlinker Adds Europe ENT Devices Market Outlook to 2017 3Reportlinker Adds Europe ENT Devices Market Outlook to 2017 4Reportlinker Adds Europe ENT Devices Market Outlook to 2017 5Reportlinker Adds Europe ENT Devices Market Outlook to 2017 6Reportlinker Adds Europe ENT Devices Market Outlook to 2017 7Reportlinker Adds Europe ENT Devices Market Outlook to 2017 8Reportlinker Adds Europe ENT Devices Market Outlook to 2017 9Reportlinker Adds Europe ENT Devices Market Outlook to 2017 10Reportlinker Adds Europe ENT Devices Market Outlook to 2017 11Reportlinker Adds Europe ENT Devices Market Outlook to 2017 12Reportlinker Adds Europe ENT Devices Market Outlook to 2017 13Boston Scientific Announces Results for First Quarter Ended March 31, 2011 2Boston Scientific Announces Results for First Quarter Ended March 31, 2011 3Boston Scientific Announces Results for First Quarter Ended March 31, 2011 4Boston Scientific Announces Results for First Quarter Ended March 31, 2011 5Boston Scientific Announces Results for First Quarter Ended March 31, 2011 6Boston Scientific Announces Results for First Quarter Ended March 31, 2011 7Boston Scientific Announces Results for First Quarter Ended March 31, 2011 8Boston Scientific Announces Results for First Quarter Ended March 31, 2011 9Boston Scientific Announces Results for First Quarter Ended March 31, 2011 10Boston Scientific Announces Results for First Quarter Ended March 31, 2011 11Boston Scientific Announces Results for First Quarter Ended March 31, 2011 12Boston Scientific Announces Results for First Quarter Ended March 31, 2011 13Boston Scientific Announces Results for First Quarter Ended March 31, 2011 14Boston Scientific Announces Results for First Quarter Ended March 31, 2011 15Boston Scientific Announces Results for First Quarter Ended March 31, 2011 16Boston Scientific Announces Results for First Quarter Ended March 31, 2011 17Boston Scientific Announces Results for First Quarter Ended March 31, 2011 18
... The NGAL ELISA Kit is intended ... fluids, (e.g. plasma, serum, urine), tissue extracts ... is dramatically increased, especially in urine, as ... and in ongoing renal repair processes. NGAL ...
... Light Head is commonly found in Heart rooms where ... the third light head being used to illuminate the ... is also a favorite in trauma rooms should there ... the same time. With 137,000 Lux output per ...
... the only medical grade DVD recorder that features ... two exclusive features DVORECOVERY™ and DVOFAST™, making this ... ever designed. DVORECOVERY enables the end user to ... outage. DVOFAST enables you to remove a recorded ...
A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....
Medicine Products: